Multiple frequency bioimpedance devices to guide fluid management in people with chronic kidney disease having dialysis

The committee recommended further research into the clinical effectiveness of BCM – Body Composition Monitor-guided fluid management in people with chronic kidney disease having dialysis. It noted that the ongoing BISTRO study will assess the effect of the device in people aged 18 years or over having haemodialysis. Further research should collect clinical-outcome data in the following populations:

• adults (aged 18 years and over) having peritoneal dialysis

• babies, children and young people (aged under 18 years) having haemodialysis

• babies, children and young people (aged under 18 years) having peritoneal dialysis.

The committee recommended that data on the effect of BCM – Body Composition Monitor-guided monitoring on health-related quality of life is collected and published. Prospective within-patient studies, which record quality of life and symptoms before and after having BCM – Body Composition Monitor-guided fluid management should be considered.